Easywell Biomedicals Statistics
Total Valuation
TPEX:1799 has a market cap or net worth of TWD 8.11 billion. The enterprise value is 8.23 billion.
Market Cap | 8.11B |
Enterprise Value | 8.23B |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:1799 has 121.79 million shares outstanding. The number of shares has increased by 5.03% in one year.
Current Share Class | n/a |
Shares Outstanding | 121.79M |
Shares Change (YoY) | +5.03% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 8.89% |
Owned by Institutions (%) | 0.03% |
Float | 55.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 14.81 |
PB Ratio | 11.29 |
P/TBV Ratio | 13.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -84.44 |
EV / Sales | 15.23 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -47.98 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.76.
Current Ratio | 1.93 |
Quick Ratio | 1.24 |
Debt / Equity | 0.76 |
Debt / EBITDA | 113.04 |
Debt / FCF | -3.29 |
Interest Coverage | -3.53 |
Financial Efficiency
Return on equity (ROE) is -12.98% and return on invested capital (ROIC) is -4.04%.
Return on Equity (ROE) | -12.98% |
Return on Assets (ROA) | -3.44% |
Return on Invested Capital (ROIC) | -4.04% |
Return on Capital Employed (ROCE) | -6.91% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.40 |
Inventory Turnover | 1.60 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.72% in the last 52 weeks. The beta is 0.48, so TPEX:1799's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | -4.72% |
50-Day Moving Average | 67.64 |
200-Day Moving Average | 109.21 |
Relative Strength Index (RSI) | 41.05 |
Average Volume (20 Days) | 778,686 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1799 had revenue of TWD 540.44 million and -97.47 million in losses. Loss per share was -0.81.
Revenue | 540.44M |
Gross Profit | 299.40M |
Operating Income | -74.79M |
Pretax Income | -88.29M |
Net Income | -97.47M |
EBITDA | -22.19M |
EBIT | -74.79M |
Loss Per Share | -0.81 |
Balance Sheet
The company has 466.10 million in cash and 564.28 million in debt, giving a net cash position of -98.19 million or -0.81 per share.
Cash & Cash Equivalents | 466.10M |
Total Debt | 564.28M |
Net Cash | -98.19M |
Net Cash Per Share | -0.81 |
Equity (Book Value) | 739.14M |
Book Value Per Share | 5.90 |
Working Capital | 394.49M |
Cash Flow
In the last 12 months, operating cash flow was -159.04 million and capital expenditures -12.49 million, giving a free cash flow of -171.53 million.
Operating Cash Flow | -159.04M |
Capital Expenditures | -12.49M |
Free Cash Flow | -171.53M |
FCF Per Share | -1.41 |
Margins
Gross margin is 55.40%, with operating and profit margins of -13.84% and -18.04%.
Gross Margin | 55.40% |
Operating Margin | -13.84% |
Pretax Margin | -16.34% |
Profit Margin | -18.04% |
EBITDA Margin | -4.11% |
EBIT Margin | -13.84% |
FCF Margin | n/a |
Dividends & Yields
TPEX:1799 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.03% |
Shareholder Yield | -5.03% |
Earnings Yield | -1.20% |
FCF Yield | -2.11% |
Stock Splits
The last stock split was on September 30, 2022. It was a reverse split with a ratio of 0.7.
Last Split Date | Sep 30, 2022 |
Split Type | Reverse |
Split Ratio | 0.7 |
Scores
TPEX:1799 has an Altman Z-Score of 9.4.
Altman Z-Score | 9.4 |
Piotroski F-Score | n/a |